Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. - Wikidata - awgldk - TriplyDB

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations.

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations.

http://www.wikidata.org/entity/Q37898591

about

Quality of life in Parkinson's disease What is quality of life and how do we measure it? Relevance to Parkinson's disease and movement disorders.Disability Rating Scales in Parkinson's Disease: Critique and Recommendations.Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures.Responsiveness of the short-form health survey and the Parkinson's disease questionnaire in patients with Parkinson's disease Assessment of Treatment Patterns and Patient Outcomes in Levodopa-Induced Dyskinesias (ASTROID): A US Chart Review Study.Determinants of generic and specific health-related quality of life in patients with Parkinson's disease Activities of daily living, depression, and quality of life in Parkinson's disease.Analysis of four scales for global severity evaluation in Parkinson's disease A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.Recurrent Falls in People with Parkinson's Disease without Cognitive Impairment: Focusing on Modifiable Risk Factors Evaluating the psychometric properties of an e-based version of the 39-item Parkinson's Disease Questionnaire.Parkinson's Disease, Depression, and Quality-of-Life.Transitions in Parkinson's disease in primary care: protocol of a longitudinal mixed methods study.Health-related quality of life as an outcome variable in Parkinson's disease.Factors influencing quality of life in caregivers of people with Parkinson's disease and implications for clinical guidelines.Non-motor symptoms of Parkinson's disease: the patient's perspective.Cognitive decline and quality of life in incident Parkinson's disease: The role of attention Medication Therapy Management Service for Patients with Parkinson's Disease: A Before-and-After Study.Factors influencing psychosocial adjustment and quality of life in Parkinson patients and informal caregivers Personality and reported quality of life in Parkinson's disease Emerging analgesic drugs for Parkinson's disease.Instruments for holistic assessment of Parkinson's disease.Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.The relevance of dopaminergic level in nocturnal disability in Parkinson's disease: implications of continuous dopaminergic stimulation at night to treat the symptoms.Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson's Disease.Outcome measurement in neurodegenerative disease: attributes, applications & interpretation.A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement.Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease.Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.The influence of depression, level of functioning in everyday life, and illness acceptance on quality of life in patients with Parkinson's disease: a preliminary study.Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.What Should Constitute a Health Related Quality of Life Scale for Parkinson's Disease?Shaking Up the Debate: Ensuring the Ethical Use of DBS Intervention Criteria for Mid-Stage Parkinson's Patients.Use of the World Health Organization Quality of Life Assessment Short Version in Mild to Moderate Parkinson Disease.Asymmetric responsiveness of disability and health-related quality of life to improvement versus decline in Parkinson's disease.Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.Levodopa-induced Dyskinesia: Clinical Features, Pathophysiology, and Medical Management.Cognitive impairments in Parkinson's disease: Evidence from an Iranian population.Determinants of health-related quality of life in people with Parkinson's disease: a path analysis.

P2860

Q26849637-C18C7C27-3272-4E31-B8B1-B82E0A4FC6F0 Q30240282-9CE07228-AD76-4D4E-81DB-F258233F197B Q30250276-B9B6714B-E9A1-4AD1-BA65-DC73A545D1AB Q30611248-D057FC0B-5C29-43CE-B603-3A5F112A6984 Q33577007-C87592D9-43B4-4747-B5A0-8D27D5017791 Q33652773-26731A4A-8606-45E0-8810-EEC81ACF7BCD Q33834634-D236D2E6-BF25-41AD-BCED-D3300B4F60AB Q33905474-8B36ED8D-7A5D-4105-966D-F8A6A8F12239 Q33917305-85FB12A4-AE9D-4354-A3D5-E4354FFDE0E0 Q34611889-28CA04FC-3528-499E-BFD7-2DDA593DAF10 Q34651698-A0F5143C-6133-455A-8016-F5B7876A6E59 Q35030328-F539A22C-F80A-4141-AEB1-E5ECBD0527EE Q35564960-87DC9209-0891-4CD6-8FEB-924A91399B4C Q35691726-9AA7EF44-2BCF-412D-A262-D69A1E27BF36 Q35825918-3A46D8A4-5472-4B64-B866-95DAA6880FA4 Q36515972-74520D84-1A13-4500-84E0-18A251231554 Q36725177-39DE4A9F-26A0-4278-9ED9-7A01097F8963 Q37000056-D371062A-1075-4C91-A084-6776D7BD23D6 Q37033702-1C5F7989-8FDD-45A1-84E8-EDFD735C9FCD Q37096093-93126BB5-B53E-4EFB-B8DE-91117827E443 Q37676917-F499961E-C6FC-4E27-91FE-266FD3463E21 Q38005224-17EF5AEF-09A2-49DC-A0D8-A514C9101E85 Q38087855-391579C1-2C03-4571-8DB1-140342031D51 Q38122127-AC403362-1AE1-4F6A-9B48-B932055DF31C Q38225785-6E60994B-B9A4-4CF8-B143-8EEF46763A91 Q38476557-0AB09A0B-3C2D-4671-8D99-FCE9CD51C213 Q38570993-7F135C01-C5ED-41D9-991D-CE2399ACFB0A Q38697121-9E5AE103-B869-4E16-A4C4-9F52C881C070 Q38751687-E2DBBAB6-D62D-44FA-8593-5A228202065B Q38811387-1805DD28-0B4F-4759-A6C0-AE1964FBCF99 Q38868216-2600E3AD-49B6-4A52-9291-A7C9CC0A11D9 Q38989994-32375B6D-5E2F-42F6-AA19-70F2D5E271A2 Q38993377-2EC6BD90-B485-43A8-95AB-F43752071789 Q39301896-62F5008F-B3BB-4428-971F-B93890C19B32 Q39655824-6056FE9A-E5C2-4346-A98E-F004FCDAC889 Q40673241-AC753DB3-B92E-45A4-8A85-F0C967732685 Q40995650-4F7BBD8B-246A-4F1E-AF99-A874014E5C9D Q41626118-7A80068C-ABCF-441A-8A16-C80BE0F28C0E Q42905690-BD1765C5-AF94-4C26-BEF6-61F53F5AD571 Q44957674-2F9DAAA7-87BF-4067-9B30-2039A579F2AC

P2860

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations.

http://www.wikidata.org/entity/Q37898591

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Health-related quality-of-life ...... critique and recommendations.

@en

Health-related quality-of-life ...... critique and recommendations.

@nl

type

label

Health-related quality-of-life ...... critique and recommendations.

@en

Health-related quality-of-life ...... critique and recommendations.

@nl

prefLabel

Health-related quality-of-life ...... critique and recommendations.

@en

Health-related quality-of-life ...... critique and recommendations.

@nl

P1433

Q37898591-D0C132FC-A144-4B87-BDD3-B31934B4DD3A

P1476

Q37898591-27747A0A-C64C-450A-9DD8-FF6A41BAE640

P2093

Q37898591-3274F0BF-DFD0-449D-9D87-3CD19F5929E7

Q37898591-5E750C19-2709-4A53-883F-8D1B9438DCF7

Q37898591-7619035C-7CF1-4E7A-8F6B-073E50D6A140

Q37898591-9EE7E1F4-EF3D-4ED6-84A8-C6D56B3C9E98

Q37898591-D49C1B3A-C943-4EF3-904D-08F37FBC3384

Q37898591-D4C37D84-CEC4-40E6-BD76-33CB6D2135A7

P2860

Q37898591-0051D928-CB05-4C50-8EF9-07F6AFCAEC96

Q37898591-055B3870-3EDB-4E5A-B6C6-B6367DC2D85C

Q37898591-061BD4B2-2232-454C-A207-7807551F2ADD

Q37898591-064F4784-BF7F-4324-80FD-8DF5FE278222

Q37898591-078D6EED-4510-491C-9808-93D6F3B8F042

Q37898591-09E67FC0-B1AC-4ABB-AF00-9219D11C7CB2

Q37898591-0C2CEA8F-0F4A-4417-8A26-42B2DBEA96F0

Q37898591-0EAEC10A-5A54-433D-9C15-4FDB586357D0

Q37898591-0F1E12BF-3E4C-4ABF-9987-BC63603CBEF5

Q37898591-108BCCF3-0DB1-474A-B4B7-8333DD72C97E

P304

Q37898591-313F6B03-4544-46E0-81B9-2A6878603D82

P31

Q37898591-1CA0A28F-AC46-4557-A986-CC400B420D2C

P356

Q37898591-0F06E639-D28B-4031-B1B6-DA6B294F4D2B

P407

Q37898591-5B26EDB2-E39D-4FD5-9784-1E4A74ACFB7A

P433

Q37898591-7EB4405D-683E-403C-ACD0-39556061CC01

P478

Q37898591-60C4F382-B3C0-4EF8-89D5-2F6B84269F51

P50

Q37898591-281EEDDA-24CB-4C04-9CBC-4C9F02132D8C

Q37898591-29569524-353E-4440-925E-58616FCFA1B9

Q37898591-4859F75E-8FDF-4AFB-8B8F-9028B6D1C684

Q37898591-86578CF4-8BE7-40CB-B45E-F93361ECC3F2

Q37898591-8C500B3B-8528-407B-9673-5B7E545ED3B5

Q37898591-9F99E746-55BC-4234-BBD1-FD5D59984D48

Q37898591-FF28735C-F027-4CE3-A1B2-470269B8FA19

P577

Q37898591-686D4E72-E0A5-4B57-BAB9-88AAABCA26E5

P5875

Q37898591-8870DA59-23D6-484A-922D-C216E81CA68E

P698

Q37898591-73436981-7D79-4DEC-9741-0A678ADDCB98

P921

Q37898591-7AD9A294-2A87-4317-BD39-91EADA13FF19

Q37898591-C0AA5D15-DB77-462D-B8BF-1BC4030C789C

P356

P1433

Movement Disorders

P1476

Health-related quality-of-life ...... critique and recommendations.

@en

P2093

Caroline Selai

http://www.w3.org/2001/XMLSchema#string

Glenn T Stebbins

http://www.w3.org/2001/XMLSchema#string

Kelly E Lyons

http://www.w3.org/2001/XMLSchema#string

Martine Jeukens-Visser

http://www.w3.org/2001/XMLSchema#string

Mickie Welsh

http://www.w3.org/2001/XMLSchema#string

Oliver Rascol

http://www.w3.org/2001/XMLSchema#string

P2860

A quantitative approach to perceived health status: a validation study.

Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments

Validity, reliability and responsiveness of the "Schedule for the Evaluation of Individual Quality of Life-Direct Weighting" (SEIQoL-DW) in congenital heart disease

The MOS 36-ltem Short-Form Health Survey (SF-36)

The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations

Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease

EuroQol--a new facility for the measurement of health-related quality of life

Cross-cultural evaluation of the Parkinson's Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain.

Testing the SF-36 in Parkinson's disease. Implications for reporting rating scale data.

A review of health-related quality-of-life concepts and measures for Parkinson's disease.

P304

2371-2380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.23834

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Cristina Sampaio

Carmen Rodriguez-Blazquez

Pablo Martinez-Martin

Christopher G. Goetz

Andrew Siderowf

P577

2011-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51473363

http://www.w3.org/2001/XMLSchema#string

P698

21735480

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

quality of life